INTERIM RESULTS FROM A PHASE 1B CLINICAL TRIAL EVALUATING TOLERABILITY AND ACTIVITY OF FGFR INHIBITION IN LOCALIZED UPPER TRACT UROTHELIAL CARCINOMA (UTUC)

被引：0
|
作者：
Matin, Surena
Adibi, Mehrad
Shah, Amishi
Alhalabi, Omar
Corn, Paul
Guo, Charles
Amirtharaj, Rhenita
Lozano, Marisa
Xiao, Lianchun
Pal, Sumanta
Campbell, Matthew
机构：
来源：
JOURNAL OF UROLOGY | 2022年 / 207卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
LBA01-10
引用
收藏
页码：E1039 / E1040
页数：2
相关论文
共 50 条
  • [1] Phase 1b Trial Evaluating Tolerability and Activity of Targeted Fibroblast Growth Factor Receptor Inhibition in Localized Upper Tract Urothelial Carcinoma
    Matin, Surena F.
    Adibi, Mehrad
    Shah, Amishi Y.
    Alhalabi, Omar
    Corn, Paul
    Guo, Charles
    Amirtharaj, Rhenita
    Xiao, Lianchun
    Lange, Suzanne
    Duose, Dzifa Y.
    Wang, Shufang
    Pal, Sumanta
    Campbell, Matthew T.
    JOURNAL OF UROLOGY, 2024, 211 (06): : 784 - 792
  • [2] PHASE II TRIAL OF NEOADJUVANT CHEMOTHERAPY FOLLOWED BY EXTIRPATIVE SURGERY FOR PATIENTS WITH HIGH GRADE UPPER TRACT UROTHELIAL CARCINOMA (HG UTUC): RESULTS FROM ECOG-ACRIN 8141
    Hoffman-Censits, Jean
    Puligandla, Maneka
    Trabulsi, Edouard
    Plimack, Elizabeth
    Kessler, Elizabeth
    Matin, Surena F.
    Godoy, Guilherme
    Alva, Ajjai
    Hahn, Noah M.
    Carducci, Michael
    Margulis, Vitaly
    JOURNAL OF UROLOGY, 2018, 199 (04): : E1166 - E1167
  • [3] Results from a Phase 1b/2 Study of Ibrutinib Combination Therapy in Advanced Urothelial Carcinoma
    Mar, Nataliya
    Zakharia, Yousef
    Falcon, Alejandro
    Morales-Barrera, Rafael
    Mellado, Begona
    Duran, Ignacio
    Oh, Do-Youn
    Williamson, Stephen K.
    Gajate, Pablo
    Arkenau, Hendrik-Tobias
    Jones, Robert J.
    Teo, Min Yuen
    Turan, Tolga
    McLaughlin, Robert T.
    Peltier, Hillary M.
    Chong, Elizabeth
    Atluri, Harisha
    Dean, James P.
    Castellano, Daniel
    CANCERS, 2023, 15 (11)
  • [4] Fibre optic ureteroscopes for the management of upper tract urothelial carcinoma? No thanks! Re: Flexible fibre optic vs digital ureteroscopy and enhanced vs unenhanced imaging for diagnosis and treatment of upper tract urothelial carcinoma (UTUC): results from the Clinical Research Office of the Endourology Society (CROES)-UTUC registry
    Ventimiglia, Eugenio
    Villa, Luca
    Salonia, Andrea
    Traxer, Olivier
    BJU INTERNATIONAL, 2022, 130 (03) : 395 - 396
  • [5] Tumor immune microenvironment analysis and MRI results of a phase II trial investigating tislelizumab (T) in the neoadjuvant treatment of high-risk upper tract urothelial carcinoma (UTUC).
    Huang, Jiwei
    Cai, Xinyun
    Ng, Cheoklong
    Luo, Yuansheng
    Wang, Zaoyu
    Kong, Wen
    Zhang, Jin
    Chen, Yonghui
    Wu, Guangyu
    Chen, Haige
    Xue, Wei
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [6] Avelumab in patients with metastatic urothelial carcinoma: Pooled results from two cohorts of the phase 1b JAVELIN Solid Tumor trial.
    Patel, Manish R.
    Ellerton, John Allan
    Infante, Jeffrey R.
    Agrawal, Manish
    Gordon, Michael S.
    Aljumaliy, Raid
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [7] Antitumor activity and safety of pembrolizumab in patients with PD-L1-positive nasopharyngeal carcinoma: Interim results from a phase 1b study
    Hsu, C.
    Lee, S. H.
    Ejadi, S.
    Even, C.
    Cohen, R.
    Le Tourneau, C.
    Mehnert, J.
    Algazi, A.
    Van Brummelen, E.
    Yuan, S. S.
    Thanigaimani, P.
    Cheng, J.
    Hansen, A.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S558 - S558
  • [8] VACCINATION WITH AN ATTENUATED HOOKWORM VACCINE: PRELIMINARY RESULTS FROM A PHASE 1B CLINICAL TRIAL
    Chapman, Paul R.
    Giacomin, Paul
    O'Rourke, Peter
    Llewellyn, Stacey
    Engwerda, Christian
    Loukas, Alex
    McCarthy, James S.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2019, 101 : 389 - 389
  • [9] Flexible fibre optic vs digital ureteroscopy and enhanced vs unenhanced imaging for diagnosis and treatment of upper tract urothelial carcinoma (UTUC): results from the Clinical Research Office of the Endourology Society (CROES)-UTUC registry
    Soria, Francesco
    Laguna, M. Pilar
    Roupret, Morgan
    Garcia-Marchinena, Patricio
    Sebastian Gonzalez, Mariano
    Habuchi, Tomonori
    Erkan, Erkan
    Ng, Anthony
    Gontero, Paolo
    Rosette, Jean de la
    BJU INTERNATIONAL, 2021, 128 (06) : 734 - 743
  • [10] PR Antitumor activity and safety of pembrolizumab in patients with PD-L1-positive nasopharyngeal carcinoma: Interim results from a phase 1b study
    Hsu, C.
    Lee, S. -H.
    Ejadi, S.
    Even, C.
    Cohen, R.
    Le Tourneau, C.
    Mehnert, J.
    Algazi, A.
    van Brummelen, E.
    Saraf, S.
    Thanigaimani, P.
    Cheng, J.
    Hansen, A.
    ANNALS OF ONCOLOGY, 2015, 26 : 94 - 94
12345